Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.9B | 7.0B | 7.0B | 6.9B |
Cost of revenue | 2.2B | 2.3B | 2.3B | 2.2B |
Gross profit | 4.7B | 4.8B | 4.6B | 4.6B |
Operating expense | ||||
Research & development | 239M | 219M | 219M | 240M |
Selling general and admin | 2.6B | 2.6B | 2.6B | 2.6B |
Other operating expenses | 10M | 8M | 60M | 4M |
Operating income | 1.9B | 1.9B | 1.8B | 1.9B |
Non operating interest income | ||||
Income | — | 52M | 28M | 34M |
Expense | 316M | 204M | 193M | 237M |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 1.8B | 1.6B | 1.6B |
Tax provision | 579M | 725M | 289M | 357M |
Net income | 912M | 1.0B | 1.3B | 1.3B |
Basic EPS | 4.1 | 4.6 | — | 5.7 |
Diluted EPS | 4.1 | 4.6 | — | 5.7 |
Basic average shares | 225.4M | 225.3M | — | 224.8M |
Diluted average shares | 225.4M | 225.3M | — | 224.8M |
EBITDA | 2.2B | 2.4B | 2.0B | 2.2B |
Net income from continuing op. | 1.8B | 1.8B | 1.9B | 1.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |